Onyx - Part of The Prime Global Group

Onyx is a specialist agency with a laser focus on orphan drugs/rare diseases, regenerative medicine including gene therapy, biosimilars and innovative medical technologies where significant unmet clinical needs exist.

Building on our deep heritage in orphan drugs/rare diseases and regenerative medicines, Onyx delivers engaging made-to-measure programmes which successfully overcome the significant and very specific communications challenges such areas present.

Onyx reflects our ability to navigate complex science and our commitment to developing communications for therapies at the cutting edge of medicine using a mix of traditional channels, exciting new innovations in the digital space and avant-garde creativity.

Mantra

Cutting-edge healthcare. Cutting-edge communications.

Prime Global Mantra

Recent Highlights

Cell Therapy Manufacturing & Gene Therapy Congress in Brussels 2016

Prime Global present Gene TherapyHoward Sinclair presenting at the Cell Therapy Manufacturing & Gene Therapy Congress in Brussels earlier this year, a  particular honour for the Onyx team.

Vacancies

We’re always looking for brilliant people to join our teams! Click the link to find out more about becoming part of Prime Global, view available roles, and apply.

Join us

Interesting Challenges

  • In many rare diseases, newborn screening is not available; identifying and diagnosing patients with rare diseases is a key challenge for healthcare professionals.

Random Fact

An estimated 350 million people worldwide have a rare disease and 30% of children with rare diseases die before their 5th birthday.* Thirty-five percent of deaths in the first year of life are caused by rare diseases.*
*Source: www.globalgenes.org

News

  • 18019062-Aventine-web-update.png

    Prime welcomes Aventine Consulting to our team

    Prime Global 29 November, 2023

    We are thrilled to announce the acquisition of Aventine Consulting LLC.

    Aventine Consulting LLC, founded by Holly Trautman and Jamie Dunning in 2008, is a US-based consulting firm specialising in US-focused market access and payer communications.

    Joining forces with Aventine will enable Prime to offer a full spectrum of health economics, market access, value communications and evidence services. Importantly, providing a local US presence to geographically support US-based global clients and meet the increasing needs of the US domestic market.

    read more >>
    , , ,
    Prime GlobalPrime welcomes Aventine Consulting to our team
  • Finalist-image.jpg

    We are PMEA Finalists!

    Prime Global 31 October, 2023

    We’re delighted to be selected as finalists at this year’s PMEA awards in the category of

    Excellence in Healthcare Professional Education and Support Programmes.

    We’re looking forward to the PMEA event in London on 22nd November.

    read more >>
    Prime GlobalWe are PMEA Finalists!
  • shutterstock_2040685925-scaled.jpg

    Caregiver education and Pharma should always go hand-in-hand: Here’s why!

    Prime Global 8 December, 2022

    Caregivers represent an integral part of patient care, yet their vital role is easily overlooked, and they often lack the informational support needed to provide optimal care for patients. For National Caregiver Month (November), Prime Patient explores how pharmaceutical companies can become “caregiver champions” by recognising the essential nature of carers’ roles and providing much needed educational support services (1). 

    read more >>
    , , ,
    Prime GlobalCaregiver education and Pharma should always go hand-in-hand: Here’s why!

Get in touch

We’re always happy to hear from you

Use the contact form or get full details for each of our offices around the world.

Contact us
Prime GlobalOnyx – Part of The Prime Group